A new form of myeloma "kidney": shortened hemofilter survival and implications for membrane filtration plasmapheresis

被引:4
作者
Dana, A. -P. [1 ]
Ahmar, C. A. [1 ]
Clapp, W. L. [2 ]
Ross, E. A. [1 ]
机构
[1] Univ Florida, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA
关键词
myeloma; CRRT; CVVH; anticoagulation; paraprotein; hollow fibers; CONTINUOUS VENOVENOUS HEMOFILTRATION; REGIONAL CITRATE ANTICOAGULATION;
D O I
10.5414/CNP75120
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite rigorous focus on extracorporeal CRRT parameters such as access, blood flow, hemoconcentration, and anticoagulation, some patients have unexpected repetitive hemofilter clotting. We instead explored patient or disease-related factors that could be responsible, and present a case of plasma cell dyscrasia in which para-proteins caused hollow fiber failure. Methods: A patient with IgG kappa chain multiple myeloma complicated by sepsis and acute renal failure was started on CVVH with a regional citrate anticoagulation protocol that typically yields filter life of > 50 h. Polysulfone hemofilters repetitively clotted every 2 - 4 h, even after excluding circuit-related problems. Failed filters were examined by light, electron (EM), and immunofluorescence (IF) microscopy. Results: Imaging of the hemofilters revealed several ultrastructural features typical for myeloma-associated alterations in native human tissue. Red cell rouleaux formation occurred within the hollow fibers. There was extensive protein layering on the luminal surface of the fibers with some extension into their walls: these deposits were IF+ for IgG kappa, and had a fibrillary substructure on EM. Conclusion: Extracorporeal hollow fiber phenomena recapitulate many intra-corporeal paraprotein effects such as those described in the kidney with plasma cell dyscrasias. Rapid protein layering suggests fouling of the membrane, decreased solute clearance before total device failure, and raises the theoretical concern that this might also occur during filtration plasmapheresis: we thus suggest serial serum free light chain levels to confirm their removal when using that technique. These findings emphasize the importance of disease rather than circuit-related factors that are under-appreciated causes of premature hemofilter failure.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 7 条
  • [1] Continuous venovenous hemofiltration with citrate-based replacement fluid: Efficacy, safety, and impact on nutrition
    Bihorac, A
    Ross, EA
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (05) : 908 - 918
  • [2] International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
    Dispenzieri, A.
    Kyle, R.
    Merlini, G.
    Miguel, J. S.
    Ludwig, H.
    Hajek, R.
    Palumbo, A.
    Jagannath, S.
    Blade, J.
    Lonial, S.
    Dimopoulos, M.
    Comenzo, R.
    Einsele, H.
    Barlogie, B.
    Anderson, K.
    Gertz, M.
    Harousseau, J. L.
    Attal, M.
    Tosi, P.
    Sonneveld, P.
    Boccadoro, M.
    Morgan, G.
    Richardson, P.
    Sezer, O.
    Mateos, M. V.
    Cavo, M.
    Joshua, D.
    Turesson, I.
    Chen, W.
    Shimizu, K.
    Powles, R.
    Rajkumar, S. V.
    Durie, B. G. M.
    [J]. LEUKEMIA, 2009, 23 (02) : 215 - 224
  • [3] Herrera GA, 2009, SILVAS DIAGNOSTIC RE, V2, P345
  • [4] Shortened hemofilter survival time due to lipid infusion in continuous renal replacement therapy
    Kazory, Amir
    Clapp, William L.
    Ejaz, A. Ahsan
    Ross, Edward A.
    [J]. NEPHRON CLINICAL PRACTICE, 2008, 108 (01): : C5 - C9
  • [5] Regional citrate anticoagulation in continuous venovenous hemodiafiltration
    Kutsogiannis, DJ
    Mayers, I
    Chin, WDN
    Gibney, RTN
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (05) : 802 - 811
  • [6] Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations
    Munjal, Sandeep
    Ejaz, A. Ahsan
    [J]. NEPHROLOGY, 2006, 11 (05) : 405 - 409
  • [7] Schetz M, 2001, CONTRIB NEPHROL, V132, P283